Showing 4 posts of 4 posts found.


Baxter partners up with Mayo Clinic for new “centre of exellence” in renal care

October 4, 2018
Research and Development Mayo Clinic, baxter, kidney disease, pharma, renal

American pharma firm Baxter has announced a new partnership with the Mayo Clinic in a bid to establish a “renal …


J&J stops Invokana trial early after success in kidney disease and type 2 diabetes

July 17, 2018
Manufacturing and Production, Research and Development J&J, JJ, Janssen, Johnson & Johnson, invokana, kidney disease, pharma, renal, type 2 diabetesm diabetes

Johnson & Johnson and research arm Janssen have taken the decision to terminate a Phase 3 trial evaluating the efficacy …


Phase III trial initiated in Merck and Pfizer partnership for renal cell carcinoma drug

April 6, 2016
Research and Development Merck, Pfizer, avelumab, carcinoma, inlyta, javelin, partnership, phase III, renal

The first patient has been treated in the Phase III clinical trial, which sees Merck (ETR: MRK) and Pfizer (NYSE: …

Head-to-head trial favours Shire’s Fosrenol

October 8, 2009
Research and Development, Sales and Marketing fosrenol, renal

Shire's Fosrenol could have a clinical advantage over rival drug Renagel from Genzyme, according to the results of what is …

Latest content